These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15298236)

  • 1. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM; Bell D; Islam SS; Scott VG
    Ann Pharmacother; 2005 Sep; 39(9):1416-22. PubMed ID: 15972326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.
    Smith DH; Kramer JM; Perrin N; Platt R; Roblin DW; Lane K; Goodman M; Nelson WW; Yang X; Soumerai SB
    Arch Intern Med; 2008 Mar; 168(5):477-83; discussion 483; quiz 447. PubMed ID: 18332291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
    Heller DA; Ahern FM; Kozak M
    Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a physician-focused educational intervention on medicaid children with asthma.
    Lee E; McNally DL; Zuckerman IH
    Ann Pharmacother; 2004 Jun; 38(6):961-6. PubMed ID: 15122003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker compliance, mortality, and reinfarction: validation of clinical trial association using insurer claims data.
    Kleiner SA; Vogt WB; Gladowski P; DeVries A; Levin G; Antonucci C; Fong J
    Am J Med Qual; 2009; 24(6):512-9. PubMed ID: 19890140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
    Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker initiation and adherence after hospitalization for acute myocardial infarction.
    Maio V; Marino M; Robeson M; Gagne JJ
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):438-45. PubMed ID: 21450641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blocker use in acute myocardial infarction in West Virginia.
    Schade CP; Brehm JG; Stephens MK; Rezek G
    W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
    Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
    Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
    Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system.
    Abbott KC; Bohen EM; Yuan CM; Yeo FE; Sawyers ES; Perkins RM; Lentine KL; Oliver DK; Galey J; Sebastianelli ME; Scally JP; Taylor AJ; Boal TR
    Am J Kidney Dis; 2006 Apr; 47(4):593-603. PubMed ID: 16564937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.